autoregressive cross lagged panel analysis

EMPLOYER BURDEN OF MILD, MODERATE, AND SEVERE MAJOR DEPRESSIVE DISORDER: MENTAL HEALTH SERVICES UTILIZATION AND COSTS, AND WORK PERFORMANCE

EFFICACY OF INTERPERSONAL THERAPY-GROUP FORMAT ADAPTED TO POST-TRAUMATIC STRESS DISORDER: AN OPEN-LABEL ADD-ON TRIAL

BARRIERS TO TREATMENT SEEKING FOR ANXIETY DISORDERS: INITIAL DATA ON THE ROLE OF MENTAL HEALTH LITERACY

ADVERSE EFFECTS OF ANTIDEPRESSANT USE IN PREGNANCY: AN EVALUATION OF FETAL GROWTH AND PRETERM BIRTH

ratio aHR=1.9, 95% confidence interval CI 1.0-3.7

SUPPORTIVE PSYCHOTHERAPY FOR PERINATAL DEPRESSION: PRELIMINARY DATA FOR ADHERENCE AND RESPONSE

b<=>5 unstandardized beta weight; Po.05; Po.01. b<=>5 unstandardized beta weight; Po0.05; Po.01

ANTIDEPRESSANT USE AMONG ASIANS IN THE UNITED STATES

bivariate ordinary least squares regression

MAJOR DEPRESSION: THE IMPORTANCE OF CLINICAL CHARACTERISTICS AND TREATMENT RESPONSE TO PROGNOSIS

ETHNIC DIFFERENCES IN ANTIDEPRESSANT RESPONSE: A PROSPECTIVE MULTI-SITE CLINICAL TRIAL

F(1,290)=15; P 5.000), more expressed suicidal ideation (31.1

ANXIETY DOES NOT PREDICT RESPONSE TO DULOXETINE IN MAJOR DEPRESSION: RESULTS OF A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 11 PLACEBO-CONTROLLED TRIALS

DIVERSITY OF EFFECTIVE TREATMENTS OF PANIC ATTACKS: WHAT DO THEY HAVE IN COMMON?

AN ADJUNCTIVE MANAGEMENT OF DEPRESSION PROGRAM FOR DIFFICULT-TO-TREAT DEPRESSED PATIENTS AND THEIR FAMILIES

DEVELOPMENT AND INITIAL VALIDATION OF THE OBSESSIVE BELIEF QUESTIONNAIRE-CHILD VERSION (OBQ-CV)

A REVIEW OF EMPIRICALLY SUPPORTED PSYCHOLOGICAL THERAPIES FOR MOOD DISORDERS IN ADULTS

n=9 reddn tseven issagn ohm eved iilitazo treeen taenn adn lteed ten redd iteyn issag 1

ACCELERATED REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION FOR TREATMENT-RESISTANT DEPRESSION

PILOT TRIAL OF DIALECTICAL BEHAVIOR THERAPY-ENHANCED HABIT REVERSAL FOR TRICHOTILLOMANIA

EFFICACY AND TOLERABILITY OF EXTENDED RELEASE QUETIAPINE FUMARATE MONOTHERAPY AS MAINTENANCE TREATMENT OF MAJOR DEPRESSIVE DISORDER: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL